Analyze Diet

Topic:Pharmacology

Pharmacology in horses involves the study and application of drugs and medications to diagnose, treat, and prevent diseases and conditions in equine species. This field encompasses the understanding of pharmacokinetics and pharmacodynamics specific to horses, including how drugs are absorbed, distributed, metabolized, and excreted by the equine body. Commonly studied pharmacological agents in horses include non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, sedatives, and anthelmintics. Research in equine pharmacology focuses on determining appropriate dosages, understanding drug interactions, and minimizing adverse effects. This page compiles peer-reviewed research studies and scholarly articles that investigate the efficacy, safety, and regulatory aspects of pharmacological interventions in equine veterinary practice.
Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol.
Toxicon : official journal of the International Society on Toxinology    August 2, 2001   Volume 39, Issue 10 1487-1494 doi: 10.1016/s0041-0101(01)00108-8
Chotwiwatthanakun C, Pratanaphon R, Akesowan S, Sriprapat S, Ratanabanangkoon K.The purpose of this study was to prepare a potent polyvalent antivenom against three elapids namely, the Thai cobra (Naja kaouthia, NK), the King cobra (Ophiophagus hannah, OH) and the banded krait (Bungarus fasciatus, BF). Two groups of horses were immunized. Group 1, comprising five horses, was immunized twice with a mixture of postsynaptic neurotoxins followed by an additional six immunizations with a mixture of crude venoms of the three elapids. Group 2, comprising four horses, was immunized with a mixture of crude venoms throughout the course. For the first immunization, the immunogens we...
The variability and repeatability of indices derived from the single-breath diagram for CO2 in horses with chronic obstructive pulmonary disease and the effect of lobelin hydrochloride on these indices.
Veterinary research communications    July 27, 2001   Volume 25, Issue 5 401-412 doi: 10.1023/a:1010698811033
Herholz C, Straub R, Busato A.Several indices of ventilatory heterogeneity can be identified from the volumetric capnogram and its graphic presentation, the single-breath diagram for CO2 (SBD-CO2). Physiologically based indices of pulmonary function (VTE, VCO2, FACO2, VDBohr% VDBohr%, VD/VTE, A1/A2) were calculated for healthy horses (group I, n = 5) and for horses with subclinical (group II, n = 7) or clinically manifest chronic obstructive pulmonary disease (COPD) (group III, n = 8) during tidal breathing and after medication with lobelin hydrochloride (Lobelin). We investigated the variability and repeatability of the l...
Endothelin in the equine hypoxic pulmonary vasoconstrictive response to acute hypoxia.
Equine veterinary journal    July 27, 2001   Volume 33, Issue 4 345-353 doi: 10.2746/042516401776249462
Benamou AE, Marlin DJ, Lekeux P.Elevated concentrations of endothelin (ET), a potent endothelium-derived vasoactive peptide, have been reported in a number of pathophysiological conditions associated with pulmonary hypertension, both in the horse and other species. We have previously shown, both in vitro and in vivo, that the pulmonary and systemic vascular response to exogenous ET is mediated predominantly via ET(A) receptors. Our hypothesis in the present study was that ET is involved in the equine hypoxic pulmonary vasoconstrictive response to acute hypoxia. In this study, we investigated the effects of a selective ET(A) ...
Intravenous pentoxifylline does not enhance the pulmonary haemodynamic efficacy of frusemide in strenuously exercising thoroughbred horses.
Equine veterinary journal    July 27, 2001   Volume 33, Issue 4 354-359 doi: 10.2746/042516401776249453
Manohar M, Goetz TE, Rothenbaum P, Humphrey S.The present study was carried out to examine whether pentoxifylline administration to horses premedicated with frusemide would attenuate the exercise-induced pulmonary arterial, capillary and venous hypertension to a greater extent than frusemide alone, thereby affecting the occurrence of exercise-induced pulmonary haemorrhage (EIPH). Using established techniques, we determined right heart and pulmonary vascular pressures in 6 healthy, sound Thoroughbred horses at rest and during exercise performed at maximal heart rate at a workload of 14 m/s on 3.5% uphill grade in the control (no medication...
Equine pulmonary and systemic haemodynamic responses to endothelin-1 and a selective ET(A) receptor antagonist.
Equine veterinary journal    July 27, 2001   Volume 33, Issue 4 337-344 doi: 10.2746/042516401776249525
Benamou AE, Marlin DJ, Lekeux P.Based on previous in vitro studies, we hypothesised that endothelin (ET) would induce vasoconstriction in the pulmonary circululation of the horse and that this action would be mediated via ET(A) receptors. Pulmonary and systemic haemodynamic responses to endothelin-1 (ET-1), a potent vasoactive endogenous peptide, were investigated in 6 conscious, nonsedated horses at rest. Bolus i.v. injections of exogenous ET-1 (0.1, 0.2 and 0.4 microg/kg bwt) caused significant increases in pulmonary (PAP) and carotid (CAP) artery pressures, with peak increases of 79% and 51% for mean PAP and CAP, respecti...
Effect of L-NAME on oxygen uptake kinetics during heavy-intensity exercise in the horse.
Journal of applied physiology (Bethesda, Md. : 1985)    July 18, 2001   Volume 91, Issue 2 891-896 doi: 10.1152/jappl.2001.91.2.891
Kindig CA, McDonough P, Erickson HH, Poole DC.There is evidence that oxidative enzyme inertia plays a major role in limiting/setting the O(2) uptake (VO(2)) response at the transition to higher metabolic rates and also that nitric oxide (NO) competitively inhibits VO(2) within the electron transport chain. To investigate whether NO is important in setting the dynamic response of VO(2) at the onset of high-intensity (heavy-domain) running in horses, five geldings were run on a treadmill across speed transitions from 3 m/s to speeds corresponding to 80% of peak VO(2) with and without nitro-L-arginine methyl ester (L-NAME), an NO synthase in...
Analgesic, hemodynamic, and respiratory effects induced by caudal epidural administration of meperidine hydrochloride in mares.
American journal of veterinary research    July 17, 2001   Volume 62, Issue 7 1001-1007 doi: 10.2460/ajvr.2001.62.1001
Skarda RT, Muir WW.To determine the analgesic, hemodynamic, and respiratory effects induced by caudal epidural administration of meperidine hydrochloride in mares. Methods: 7 healthy mares. Methods: Each mare received meperidine (5%; 0.8 mg/kg of body weight) or saline (0.9% NaCl) solution via caudal epidural injection on 2 occasions. At least 2 weeks elapsed between treatments. Degree of analgesia in response to noxious electrical, thermal, and skin and muscle prick stimuli was determined before and for 5 hours after treatment. In addition, cardiovascular and respiratory variables were measured and degree of se...
Effects of enalaprilat on cardiorespiratory, hemodynamic, and hematologic variables in exercising horses.
American journal of veterinary research    July 17, 2001   Volume 62, Issue 7 1008-1013 doi: 10.2460/ajvr.2001.62.1008
Muir WW, Sams RA, Hubbell JA, Hinchcliff KW, Gadawski J.To determine the effects of IV administration of enalaprilat on cardiorespiratory and hematologic variables as well as inhibition of angiotensin converting enzyme (ACE) activity in exercising horses. Methods: 6 adult horses. Methods: Horses were trained by running on a treadmill for 5 weeks. Training was continued throughout the study period, and each horse also ran 2 simulated races at 120% of maximum oxygen consumption. Three horses were randomly selected to receive treatment 1 (saline [0.9% NaCl] solution), and the remaining 3 horses received treatment 2 (enalaprilat; 0.5 mg/kg of body weig...
Ropivacaine in the horse: its pharmacological responses, urinary detection and mass spectral confirmation.
Journal of veterinary pharmacology and therapeutics    July 10, 2001   Volume 24, Issue 2 89-98 doi: 10.1046/j.1365-2885.2001.00314.x
Harkins JD, Karpiesiuk W, Lehner A, Woods WE, Dirikolu L, Carter WG, Boyles J, Tobin T.This report evaluates the pharmacological responses, urinary detection and mass spectral confirmation of ropivacaine in horses. Ropivacaine, a potent local anesthetic (LA) recently introduced in human medicine, has an estimated highest no-effect dose (HNED) of about 0.4 mg/site as determined in our abaxial sesamoid block model. Apparent ropivacaine equivalents were detectable by ELISA screening using a mepivacaine ELISA test after administration of clinically effective doses. Mass spectral examination of postadministration urine samples showed no detectable parent ropivacaine, but a compound i...
Effects of 8-epi-PGF2alpha on isolated bronchial smooth muscle of healthy and heaves-affected horses.
Journal of veterinary pharmacology and therapeutics    July 10, 2001   Volume 24, Issue 3 215-221 doi: 10.1046/j.1365-2885.2001.00330.x
Kirschvink N, Art T, Lekeux P, Roberts C, Gustin P.8-Epi-PGF2alpha, a prostaglandin-like compound generated by oxidative stress, has been shown to be an in vitro bronchoconstrictor in airways from healthy laboratory animals and healthy humans, but it has never been studied in diseased airways. Here, the bronchoconstrictive capacity of 8-epi-PGF2alpha on isolated bronchial rings (BR) of healthy and heaves-affected horses was evaluated by comparing the maximal effect and the potency of 8-epi-PGF2alpha to those of (1) acetylcholine (ACh), (2) its stereoisomer PGF2alpha and (3) its synthetic receptor agonist, U46619. Furthermore, the potential cap...
Enantiospecific pharmacokinetics of ketoprofen in plasma and synovial fluid of horses with acute synovitis.
Journal of veterinary pharmacology and therapeutics    July 10, 2001   Volume 24, Issue 3 179-185 doi: 10.1046/j.1365-2885.2001.00336.x
Verde CR, Simpson MI, Frigoli A, Landoni MF.Pharmacokinetic parameters were established for enantiomers of the nonsteroidal anti-inflammatory drug (NSAID) ketoprofen (KTP) administered as the racemic mixture at a dose of 2.2 mg/kg and as separate enantiomers, each at a dose of 1.1 mg/kg to a group of six horses (five mares and one gelding). A four-period cross-over study in a LPS-induced model of acute synovitis was used. After administration of the racemic mixture S(+)KTP was the predominant enantiomer in plasma as well as in synovial fluid. Unidirectional inversion of R(-) to S(+)KTP was demonstrated but the inversion was less marked ...
[Equine estrogens vs. esterified estrogens in the climacteric and menopause. The controversy arrives in Mexico].
Gaceta medica de Mexico    July 4, 2001   Volume 137, Issue 3 237-242 
Velasco-Murillo V.It exists controversies about if the effects and benefits of the esterified estrogens could be similar to those informed for equines, because its chemical composition and bioavailability are different. Esterified estrogens has not delta 8,9 dehydroestrone, and its absorption and level of maximum plasmatic concentrations are reached very fast. In United States of America and another countries, esterified estrogens has been marketed and using for treatment of climacteric syndrome and prevention of postmenopausal osteoporosis, based on the pharmacopoiea of that country, but the Food and Drug admi...
Safety of ponazuril 15% oral paste in horses.
Veterinary therapeutics : research in applied veterinary medicine    July 1, 2001   Volume 2, Issue 3 223-231 
Kennedy T, Campbell J, Selzer V.Ponazuril, a triazine-derivative compound, is proposed as a treatment for equine protozoal myeloencephalitis caused by Sarcocystis neurona. Ponazuril 15% oral paste was administered to 24 horses at 0, 10, or 30 mg/kg body weight for either 28 or 56 days, representing zero, two, and six times the proposed dosage rate and one and two times the recommended duration of treatment, respectively. Serum chemistry analysis, coagulation profile, and hematology measurements were performed weekly and necropsy evaluations, including histopathology, were conducted for all animals at the end of the study. Mi...
The effects of pyrantel tartrate on Sarcocystis neurona merozoite viability.
Veterinary therapeutics : research in applied veterinary medicine    July 1, 2001   Volume 2, Issue 3 268-276 
Kruttlin EA, Rossano MG, Murphy AJ, Vrable RA, Kaneene JB, Schott HC, Mansfield LS.Sarcocystis neurona is the etiologic agent of equine protozoal myeloencephalitis, a neurologic disease of horses. The present study was designed to test the hypothesis that pyrantel tartrate can kill S. neurona merozoites growing in equine dermal cell culture. Sarcocystis neurona merozoites were exposed to a range of concentrations of pyrantel tartrate or sodium tartrate ranging from 0.001 to 0.01 M. Merozoites were then placed onto equine dermal cell cultures and incubated for 2 weeks to check for viability. At 1 and 2 weeks after inoculation, plaque counts were compared between treatments an...
Efficacy of ponazuril 15% oral paste as a treatment for equine protozoal myeloencephalitis.
Veterinary therapeutics : research in applied veterinary medicine    July 1, 2001   Volume 2, Issue 3 215-222 
Furr M, Kennedy T, MacKay R, Reed S, Andrews F, Bernard B, Bain F, Byars D.Equine protozoal myeloencephalitis (EPM) is a neurologic disease of horses most commonly caused by the protozoan parasite Sarcocystis neurona. Until recently the only treatment option was the combination of a sulfonamide with pyrimethamine. The present study was performed to assess the efficacy of ponazuril, an anticoccidial triazine-based compound, as a treatment for naturally occurring EPM. One hundred one horses with EPM were randomly allocated to treatment with ponazuril 15% oral paste at either 5 or 10 mg/kg body weight for 28 consecutive days. Horses were evaluated clinically and by anal...
Re-evaluation of ivermectin efficacy against equine gastrointestinal parasites.
Veterinary parasitology    June 26, 2001   Volume 98, Issue 4 315-320 doi: 10.1016/s0304-4017(01)00436-8
Klei TR, Rehbein S, Visser M, Langholff WK, Chapman MR, French DD, Hanson P.Two trials were conducted to confirm the efficacy of ivermectin paste against endoparasites of horses. In these trials, 20 ponies were treated with ivermectin oral paste at 200 mcg x kg body weight once on Day 0, and 20 ponies served as unmedicated controls. The animals carried naturally acquired parasite infections as confirmed by pretrial fecal examination. The animals were necropsied for worm recovery on Days 14, 15 or 16. Parasites recovered were identified to species. Horses treated with ivermectin had significantly (P99.0% reduction) adult small strongyles (Coronocyclus spp including C. ...
Prevalence and clinical implications of anthelmintic resistance in cyathostomes of horses.
Journal of the American Veterinary Medical Association    June 22, 2001   Volume 218, Issue 12 1957-1960 doi: 10.2460/javma.2001.218.1957
Tarigo-Martinie JL, Wyatt AR, Kaplan RM.To determine the prevalence and clinical implications of anthelmintic resistance in cyathostomes of horses. Methods: Prospective study. Methods: 80 horses on 10 farms in a 5-county region of northeast Georgia. Methods: On each farm, horses were stratified in descending order according to pretreatment fecal egg count (FEC), blocked into groups of 4, and then randomly assigned to 1 of 4 treatment groups: no treatment (controls), and treatment with pyrantel pamoate, fenbendazole, or ivermectin. Fecal samples were collected 24 hours prior to treatment and 2, 4, and 6 weeks after treatment for dete...
Induction of luteolysis in mares by ultrasound-guided intraluteal treatment with PGF2alpha.
Theriogenology    June 21, 2001   Volume 55, Issue 9 1769-1776 doi: 10.1016/s0093-691x(01)00519-2
Weber JA, Causey RC, Emmans EE.To evaluate the technique of ultrasound-guided luteal injection in mares, PGF2alpha was administered under ultrasound guidance to horse mares (n = 7 to 9 per group) on Day 9 postovulation via either a systemic (i.m.; zero, 0.01, 0.1, or 5 mg/dose) route or a local intraluteal (i.l.; zero, 0.01 or 0.1 mg/dose) route. The luteolytic efficacy of each treatment was determined based on post-treatment decreases in progesterone concentration, interval to uterine edema (IE) and interovulatory interval (IOI). Local administration of PGF2alpha directly into the CL consistently induced luteolysis, at dos...
The effect of sodium heparin on equine articular cartilage.
Veterinary journal (London, England : 1997)    June 21, 2001   Volume 162, Issue 1 73-79 doi: 10.1053/tvjl.2001.0585
McCarthy HE, Singer ER, Davies Morel MC.This study compared the effect of sodium heparin and gentamicin sulphate on equine articular cartilage (AC) explants in order to investigate the possible use of sodium heparin in the treatment of infectious arthritis. Six concentrations of sodium heparin and gentamicin sulphate were tested. The supernatant and explant digest were assayed for glycosaminoglycan (GAG) content with the dimethyl-methylene blue assay and the per cent loss of GAG was calculated. A significant (P< 0.001) increase in percentage GAG loss was noted for the sodium heparin groups when compared to the control, whilst no ...
Time-related changes of the cardiovascular system during maintenance anesthesia with sevoflurane and isoflurane in horses.
The Journal of veterinary medical science    June 20, 2001   Volume 63, Issue 5 527-532 doi: 10.1292/jvms.63.527
Yamanaka T, Oku K, Koyama H, Mizuno Y.To clarify time-related changes in equine cardiovascular system during maintenance anesthesia (180 min, 1.2 minimum alveolar concentration) with sevoflurane (Sev-group) compared to isoflurane (Iso-group) as the basis for clinical use of Sev, horses were examined for the heart rate (HR), mean arterial pressure (MAP), cardiac index (CI), systemic vascular resistance (SVR) and pre-ejection period (PEP)/ejection time (ET) that is an index of the cardiac contractility. The HR was almost 30 beats/min in both groups without significant temporal change. MAP was significantly elevated with time but the...
Effects of caffeine on locomotor activity of horses: determination of the no-effect threshold.
Journal of applied toxicology : JAT    June 19, 2001   Volume 21, Issue 3 229-234 doi: 10.1002/jat.748
Queiroz-Neto A, Zamur G, Carregaro AB, Mataqueiro MI, Salvadori MC, Azevedo CP, Harkins JD, Tobin T.Caffeine is the legal stimulant consumed most extensively by the human world population and may be found eventually in the urine and/or blood of race horses. The fact that caffeine is in foods led us to determine the highest no-effect dose (HNED) of caffeine on the spontaneous locomotor activity of horses and then to quantify this substance in urine until it disappeared. We built two behavioural stalls equipped with juxtaposed photoelectric sensors that emit infrared beams that divide the stall into nine sectors in a 'tic-tac-toe' fashion. Each time a beam was interrupted by a leg of the horse...
Effect of topical 1% atropine sulfate on intraocular pressure in normal horses.
Veterinary ophthalmology    June 9, 2001   Volume 3, Issue 2-3 139-143 doi: 10.1046/j.1463-5224.2000.00134.x
Herring IP, Pickett JP, Champagne ES, Troy GC, Marini M.OBJECTIVE: To determine the effect of topical 1% ophthalmic atropine sulfate on intraocular pressure (IOP) in ocular normotensive horses. Animals Studied Eleven clinically healthy horses. Procedures IOP was measured bilaterally twice daily, at 8 AM and 4 PM, for 5 days. No medication was applied for the first 2 days of the study. Thereafter, one eye of each horse was treated with 0.1 mL of topical 1% atropine sulfate ointment twice daily (7 AM and 7 PM) for 3 days. The contralateral eye served as a control. In eight of the horses, an additional IOP reading was taken 3 days following cessation ...
Effect of topical atropine on intraocular pressure and pupil diameter in the normal horse eye.
Veterinary ophthalmology    June 9, 2001   Volume 2, Issue 4 213-215 doi: 10.1046/j.1463-5224.1999.00081.x
Mughannam AJ, Buyukmihci NC, Kass PH.The objective was to determine whether topically administered 1% atropine would alter intraocular pressure. The animals studied were four healthy adult horses. Intraocular pressure and pupil diameter were measured prior to and during a 2-day period of treatment with 1% atropine sulfate. No significant changes in intraocular pressure occurred as a result of the treatment with atropine. Pupil diameter increased significantly after atropine was applied. Available information on the outflow of aqueous humor from the horse eye suggests that atropine might reduce intraocular pressure in the horse by...
Systemic effects of topical and subconjunctival ophthalmic atropine in the horse.
Veterinary ophthalmology    June 9, 2001   Volume 3, Issue 2-3 193-199 doi: 10.1046/j.1463-5224.2000.00118.x
Williams MM, Spiess BM, Pascoe PJ, O'Grady M.OBJECTIVE: To identify any systemic effects of topical and subconjunctival administration of atropine sulfate in the horse. Animals studied Six mature grade horses were treated hourly in one eye with topical ophthalmic atropine drops for 24 h. Five horses were treated subconjunctivally in one eye with 3 mg of atropine sulfate. Procedures Pupillary light reflexes, pupil size, electrocardiographic parameters, girth measurements, intestinal motility, and clinical signs of abdominal pain were monitored. RESULTS: Alteration in auscultated gut motility and clinical signs of abdominal pain were the m...
Evaluation of tear film proteinases in horses with ulcerative keratitis.
Veterinary ophthalmology    June 9, 2001   Volume 3, Issue 2-3 111-119 doi: 10.1046/j.1463-5224.2000.00093.x
Strubbe DT, Brooks DE, Schultz GS, Willis-Goulet H, Gelatt KN, Andrew SE, Kallberg ME, MacKay EO, Collante WR.Ulcerative keratitis is a common and potentially blinding ocular disease of horses, capable of progressing to corneal perforation in as little as 24 h. This rapid stromal degeneration is mediated in part by exogenous and endogenous proteinases. We measured and compared the concentrations of two matrix metalloproteinases (MMP-2 and MMP-9) and a serine proteinase (neutrophil elastase) present in the precorneal tear film of normal horses and horses with rapidly progressing ulcerative keratitis. Precorneal tear film samples were collected from 23 ulcerated and 21 unaffected eyes of 23 horses with ...
Effect of single- and multiple-dose 0.5% timolol maleate on intraocular pressure and pupil size in female horses.
Veterinary ophthalmology    June 9, 2001   Volume 3, Issue 2-3 165-168 doi: 10.1046/j.1463-5224.2000.00126.x
Van Der Woerdt A, Wilkie DA, Gilger BC, Strauch SM, Orczeck SM.OBJECTIVE: To determine the effect of single and multiple-dose 0.5% timolol maleate on intraocular pressure (IOP) and pupil size between 8 AM and 8 PM. Animals Nine female horses with normotensive eyes. Procedure IOP, horizontal and vertical pupil size were measured on a single day, between 8 AM and 8 PM at hours 0, 0.5, 1, 2, 4, 6, 8, 10, and 12. A single dose of 0.5% timolol maleate was applied to both eyes immediately after the first measurement at 8 AM. IOP and pupil size were measured at 8 AM and 4 PM in a 5-day experiment of twice-daily application of 0.5% timolol maleate. RESULTS: A sig...
The effect of the gonadotropin-releasing hormone analog, buserelin, on pregnancy rates in horse and pony mares.
Theriogenology    June 8, 2001   Volume 55, Issue 8 1619-1631 doi: 10.1016/s0093-691x(01)00507-6
Newcombe JR, Martinez TA, Peters AR.We conducted a series of trials over a four-year period on a total of 2,346 mares, to determine the effect of a single dose of the GnRH analog buserelin (20 to 40 microg i.m. or s.c.) on pregnancy rates when given between 8 and 12 days after service. Although there were some statistically significant improvements in pregnancy rates in individual trials, meta-analysis of the data overall showed significant improvements at all times examined, i.e. 13 to 16, 19 to 23, 28 to 31 and 38 to 42 days after service. These results indicate that treatment of mares with 20 to 40 microg buserelin between Da...
Use of buserelin to induce ovulation in the cyclic mare.
Theriogenology    June 8, 2001   Volume 55, Issue 8 1679-1695 doi: 10.1016/s0093-691x(01)00512-x
Barrier-Battut I, Le Poutre N, Trocherie E, Hecht S, Grandchamp des Raux A, Nicaise JL, Vérin X, Bertrand J, Fiéni F, Hoier R, Renault A, Egron L....Inducing ovulation in a cyclic mare is often necessary. For this purpose, hCG has been used commonly, but the response can be reduced after successive administrations. The aims of this study were to test the effectiveness of buserelin in hastening ovulation in estrus mares, and its influence on fertility; and to investigate the effect of treatment on LH secretion. Five crossover trials were designed to compare the effect of two treatments: buserelin (40 microg in 4 doses i.v. at 12 h intervals) vs placebo (Experiments 1 and 2); buserelin 40 microg (in 4 doses i.v.) vs 20 microg (Experiment 3);...
Clenbuterol in the horse: confirmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration.
Journal of analytical toxicology    June 2, 2001   Volume 25, Issue 4 280-287 doi: 10.1093/jat/25.4.280
Lehner AF, Harkins JD, Karpiesiuk W, Woods WE, Robinson NE, Dirikolu L, Fisher M, Tobin T.Clenbuterol is a beta2 agonist/antagonist bronchodilator, and its identification in post-race samples may lead to sanctions. The objective of this study was to develop a specific and highly sensitive serum quantitation method for clenbuterol that would allow effective regulatory control of this agent in horses. Therefore, clenbuterol-d9 was synthesized for use as an internal standard, an automated solid-phase extraction method was developed, and both were used in conjunction with a multiple reaction monitoring liquid chromatography-tandem mass spectrometry (LC-MS-MS) method to allow unequivoca...
Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding.
Fertility and sterility    June 1, 2001   Volume 75, Issue 6 1080-1087 doi: 10.1016/s0015-0282(01)01792-7
Archer DF, Dorin M, Lewis V, Schneider DL, Pickar JH.To evaluate vaginal bleeding profiles with lower doses of conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA) as continuous combined therapy. Methods: The Women's Health, Osteoporosis, Progestin, Estrogen (Women's HOPE) study, a randomized, double-blind, placebo-controlled trial. Methods: Study centers across the United States. Methods: Two thousand six hundred seventy-three healthy, postmenopausal women. Methods: Women received CEE, 0.625 mg/d; CEE, 0.625 mg/d, plus MPA 2.5 mg/d; CEE, 0.45 mg/d; CEE, 0.45 mg/d, plus MPA, 2.5 mg/d; CEE 0.45 mg/d, plus MPA, 1.5 mg/d; CEE, 0....
1 85 86 87 88 89 173